| Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression A Sreekumar, LM Poisson, TM Rajendiran, AP Khan, Q Cao, J Yu, ... Nature 457 (7231), 910-914, 2009 | 2505 | 2009 |
| Autoantibody signatures in prostate cancer X Wang, J Yu, A Sreekumar, S Varambally, R Shen, D Giacherio, R Mehra, ... New England Journal of Medicine 353 (12), 1224-1235, 2005 | 758 | 2005 |
| Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming L Tian, A Goldstein, H Wang, H Ching Lo, IK Sun Kim, T Welte, K Sheng, ... Nature 544 (7649), 250-254, 2017 | 631 | 2017 |
| Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins A Sreekumar, MK Nyati, S Varambally, TR Barrette, D Ghosh, ... Cancer research 61 (20), 7585-7593, 2001 | 460 | 2001 |
| A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification D Mueller, C Bach, D Zeisig, MP Garcia-Cuellar, S Monroe, A Sreekumar, ... Blood, The Journal of the American Society of Hematology 110 (13), 4445-4454, 2007 | 449 | 2007 |
| Circadian homeostasis of liver metabolism suppresses hepatocarcinogenesis NM Kettner, H Voicu, MJ Finegold, C Coarfa, A Sreekumar, N Putluri, ... Cancer cell 30 (6), 909-924, 2016 | 423 | 2016 |
| Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells W Fiskus, Y Wang, A Sreekumar, KM Buckley, H Shi, A Jillella, C Ustun, ... Blood, The Journal of the American Society of Hematology 114 (13), 2733-2743, 2009 | 422 | 2009 |
| MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis A Terunuma, N Putluri, P Mishra, EA Mathé, TH Dorsey, M Yi, TA Wallace, ... The Journal of clinical investigation 124 (1), 398-412, 2014 | 421 | 2014 |
| Fatty acid oxidation-driven Src links mitochondrial energy reprogramming and oncogenic properties in triple-negative breast cancer JH Park, S Vithayathil, S Kumar, PL Sung, LE Dobrolecki, V Putluri, ... Cell reports 14 (9), 2154-2165, 2016 | 286 | 2016 |
| Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression Q Hu, Y Ye, LC Chan, Y Li, K Liang, A Lin, SD Egranov, Y Zhang, W Xia, ... Nature immunology 20 (7), 835-851, 2019 | 283 | 2019 |
| Molecular profiling reveals unique immune and metabolic features of melanoma brain metastases GM Fischer, A Jalali, DA Kircher, WC Lee, JL McQuade, LE Haydu, ... Cancer discovery 9 (5), 628-645, 2019 | 269 | 2019 |
| Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms IS Kim, Y Gao, T Welte, H Wang, J Liu, M Janghorban, K Sheng, Y Niu, ... Nature cell biology 21 (9), 1113-1126, 2019 | 252 | 2019 |
| Expression profile of prostate cancer AM Chinnaiyan, MA Rubin, A Sreekumar US Patent 7,229,774, 2007 | 241 | 2007 |
| Humoral immune response to α-methylacyl-CoA racemase and prostate cancer A Sreekumar, B Laxman, DR Rhodes, S Bhagavathula, J Harwood, ... Journal of the National Cancer Institute 96 (11), 834-843, 2004 | 221 | 2004 |
| The role of sarcosine metabolism in prostate cancer progression AP Khan, TM Rajendiran, A Bushra, IA Asangani, JN Athanikar, ... Neoplasia 15 (5), 491-IN13, 2013 | 207 | 2013 |
| Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression N Putluri, A Shojaie, VT Vasu, SK Vareed, S Nalluri, V Putluri, ... Cancer research 71 (24), 7376-7386, 2011 | 198 | 2011 |
| Copper & biological health S Krupanidhi, A Sreekumar, CB Sanjeevi Indian Journal of Medical Research 128 (4), 448-461, 2008 | 159 | 2008 |
| Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer AP Khan, LM Poisson, VB Bhat, D Fermin, R Zhao, S Kalyana-Sundaram, ... Molecular & Cellular Proteomics 9 (2), 298-312, 2010 | 155 | 2010 |
| Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunate AM Lisewski, JP Quiros, CL Ng, AK Adikesavan, K Miura, N Putluri, ... Cell 158 (4), 916-928, 2014 | 147 | 2014 |
| Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer S Varambally, B Laxman, R Mehra, Q Cao, SM Dhanasekaran, ... Neoplasia 10 (11), 1285-IN35, 2008 | 147 | 2008 |
